Idexx Laboratories

IDXXNasdaq United States Health Care Biotechnology: In Vitro & In Vivo Diagnostic Substances

Market cap

$40.596 B

$515.30 +0.71%

Close of 21 Sept 2026

Revenue

$4.30B

#748 by revenue

Earnings

$1.06B

#376 by earnings

Shares outstanding

78,781,116

Latest filing cover page

P/E ratio

38.3

Cap ÷ net income

Biotechnology: In Vitro & In Vivo Diagnostic Substances, ranked by market cap

All 19 →

#1Idexx LaboratoriesIDXX$40.6B
#2LantheusLNTH$6.55B
#3Oruka TherapeuticsORKA$6.18B
#4Celldex TherapeuticsCLDX$2.98B
#5NeogenNEOG$2.97B

What if Idexx Laboratories were worth as much as…

Open the what-if tool →

Gold $30.3T

$384,280.60

Per share 746× higher

Bitcoin $1.72T

$21,830.15

Per share 42.4× higher

Nvidia $5.48T

$69,558.01

Per share 135× higher

Or at a round number

$50.0B $100.0B $200.0B $500.0B

Where these numbers come from

Share counts and financials for Idexx Laboratories are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 22 Sept 2026. Read the methodology.